Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Arteriosclerosis

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Arteriosclerosis in 44 studies

Research

Studies (44)

TimeframeStudies, this research(%)All Research%
pre-199012 (27.27)18.7374
1990's18 (40.91)18.2507
2000's14 (31.82)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
John Chapman, M; Tselepis, AD1
Antonopoulou, S; Demopoulos, CA; Fragopoulou, E; Nomikos, T1
Baron, P; Camussi, G; Del Sorbo, L; Emanuelli, G; Forni, M; Lupia, E; Merlo, M; Montrucchio, G; Peasso, P; Pucci, A; Rizea-Savu, S; Silvestro, L; Zanini, C1
Angeli, V; Fisher, EA; Liu, J; Llodrá, J; Randolph, GJ; Trogan, E1
Angeli, V; Fisher, EA; Ishii, S; Llodrá, J; Randolph, GJ; Rong, JX; Satoh, K; Shimizu, T1
Ninio, E1
Azuma, J; Fujio, Y; Maeda, M; Matsuda, T; Nariai, T; Sumita, C; Yamane, M1
Dyerberg, J; Jørgensen, KA1
Evangelou, AM1
Häyry, P; Mennander, A; Paavonen, T; Räisänen, A; Ustinov, J1
Saito, H; Tamura, Y1
Henry, PD; Kerns, SA; Kugiyama, K; Mangin, EL; Nguy, JH1
Chapman, MJ; Dentan, C; Lesnik, P; Ninio, E1
McIntyre, TM; Prescott, SM; Stafforini, DM; Zimmerman, GA1
Barnathan, ES; Buck, CA; Cines, DB; Hug, BA; Konkle, BA; Loscalzo, J; McCrae, KR; McEver, RP; Pober, JS; Pollak, ES; Schmidt, AM; Schwartz, BS; Stern, DM; Wick, TM; Zimmerman, GA1
Durrington, PN; Mackness, B; Mackness, MI1
Fogarty, DG; Hasselwander, O; Maxwell, AP; McEneny, J; McMaster, D; Nicholls, DP; Young, IS1
Gerritsen, ME; Granger, DN; Horie, Y; Mori, N1
Calabrese, S; Delbello, C; Dobrina, A; Fiotti, N; Giansante, C; Guarnieri, G; Ponte, E; Zacchi, T1
Berliner, JA; Faull, KF; Leitinger, N; Shih, PT; Subbanagounder, G1
De Faire, U; Frostegârd, J; Lemne, C; Wu, R1
Ichihara, S; Imaizumi, T; Satoh, K; Yamada, Y; Yokota, M; Yoshida, H1
Caslake, MJ; Chamberlain, P; Holmes, SD; Macphee, CH; Packard, CJ; Suckling, KE1
Kaneko, H; Miwa, M; Nakamura, S; Nakamura, T; Sugatani, J; Uchiyama, T; Unno, N; Yamamoto, N1
Fukuzawa, K; Kogure, K; Sumida, T; Tokumura, A; Toujima, M1
Sachais, BS1
Chapman, MJ; Hourton, D; Ninio, E; Stengel, D1
Antonopoulou, S; Demopoulos, CA; Fragopoulou, E1
Block, LH; Bühler, FR1
Armstrong, ML; Densen, P; Heistad, DD; Lopez, JA; Mügge, A; Padgett, RC; Piegors, DJ1
Braquet, PG; Koltai, M1
Sellmayer, A; Weber, PC1
Hiramoto, M; Imaizumi, T; Kawamura, Y; Koyanagi, M; Satoh, K; Takamatsu, M; Takamatsu, S; Yoshida, H1
Armstrong, ML; Harrison, DG; Heistad, DD; Lopez, JA; Piegors, DJ1
Chambers, E; Foegh, ML; Khirabadi, BS; Nakanishi, T; Ramwell, PW1
Braquet, P; Chap, H; Feliste, R; Perret, B1
Beilin, LJ; Kendrew, PJ; Strophair, JM; Sturm, MJ; Taylor, RR; Vandongen, R1
Apprill, P; Ashton, J; Buja, LM; Campbell, WB; Raheja, S; Schmitz, JM; Tilton, G; Willerson, JT1
Arese, P; Biffignandi, P; Bussolino, F1
Dejana, E; Fuster, V; Lapetina, E; Moncada, S; Mustard, JF; Tans, G; Vargaftig, BB; Verstraete, M1
Holtz, H; Lang, A; Ostermann, G; Rühling, K; Till, U; Winkler, L1
Parthasarathy, S; Quinn, MT; Steinberg, D1
Hiramoto, M; Imaizumi, T; Kawamura, Y; Satoh, K; Takamatsu, S; Yoshida, H1
Ostermann, G; Rühling, K; Schlag, B; Till, U; Winkler, L; Zabel-Langhennig, R1

Reviews

13 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Arteriosclerosis

ArticleYear
Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase.
    Atherosclerosis. Supplements, 2002, Volume: 3, Issue:4

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Arteriosclerosis; Humans; Inflammation; Lipids; Phospholipases A; Phospholipases A2; Platelet Activating Factor

2002
Phospholipid mediators in the vessel wall: involvement in atherosclerosis.
    Current opinion in clinical nutrition and metabolic care, 2005, Volume: 8, Issue:2

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Arteriosclerosis; Endothelium, Vascular; Humans; Phospholipases A2; Phospholipids; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled

2005
Platelets and atherosclerosis.
    Advances in nutritional research, 1983, Volume: 5

    Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arteriosclerosis; Blood Platelets; Blood Vessels; Dietary Fats; Eicosapentaenoic Acid; Epoprostenol; Fatty Acids, Unsaturated; Hemostasis; Humans; Lipid Peroxides; Mitogens; Platelet Activating Factor; Platelet Aggregation; Thromboxanes

1983
Platelet-activating factor (PAF): implications for coronary heart and vascular diseases.
    Prostaglandins, leukotrienes, and essential fatty acids, 1994, Volume: 50, Issue:1

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Arteriosclerosis; Blood Vessels; Coronary Disease; Cytokines; Endothelium, Vascular; Humans; Phospholipases A; Platelet Activating Factor; Vascular Diseases; Vasculitis

1994
[Antiatherogenic action of omega-3 polyunsaturated fatty acids].
    Nihon rinsho. Japanese journal of clinical medicine, 1993, Volume: 51, Issue:8

    Topics: Animals; Arteriosclerosis; Blood Pressure; Endothelium, Vascular; Epoprostenol; Fatty Acids, Omega-3; Humans; Lipids; Macrophage Activation; Monocytes; Platelet Activating Factor; Platelet Aggregation

1993
Inflammation as an early component of atherosclerosis and vascular damage--a role for P-selectin and platelet-activating factor.
    Japanese circulation journal, 1996, Volume: 60, Issue:3

    Topics: Arteriosclerosis; Cells, Cultured; Endothelium, Vascular; Humans; Leukocytes; Muscle, Smooth, Vascular; P-Selectin; Platelet Activating Factor; Time Factors; Vasculitis

1996
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
    Blood, 1998, May-15, Volume: 91, Issue:10

    Topics: Animals; Arteriosclerosis; Blood Cells; Blood Coagulation; Cell Adhesion; Cell Adhesion Molecules; Cell Differentiation; Cells, Cultured; Endothelial Growth Factors; Endothelins; Endothelium, Vascular; Epoprostenol; Extracellular Matrix; Female; Fibrinolysis; Fibroblast Growth Factor 2; Hemodynamics; Humans; Inflammation; Lymphokines; Male; Mice; Neovascularization, Physiologic; Nitric Oxide; Platelet Activating Factor; Pre-Eclampsia; Pregnancy; Thrombosis; Umbilical Veins; Vascular Diseases; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

1998
Platelet-activating factor (PAF)-like oxidized phospholipids: relevance to atherosclerosis.
    BioFactors (Oxford, England), 2000, Volume: 13, Issue:1-4

    Topics: Animals; Arteriosclerosis; DNA; Humans; Lipid Peroxidation; Lipoproteins, LDL; Muscle, Smooth, Vascular; Phospholipids; Platelet Activating Factor

2000
Platelet-endothelial interactions in atherosclerosis.
    Current atherosclerosis reports, 2001, Volume: 3, Issue:5

    Topics: Antigens, CD; Apyrase; Arteriosclerosis; Blood Platelets; Carrier Proteins; Cell Adhesion; Cell Adhesion Molecules; Cell Communication; Endothelium, Vascular; Epoprostenol; Humans; Hypolipidemic Agents; Nitric Oxide; Nitric Oxide Synthase; P-Selectin; Platelet Activating Factor; Receptors, LDL; Receptors, Oxidized LDL; Scavenger Receptors, Class E; Ubiquitin-Protein Ligases

2001
Involvement of PAF in atherogenesis. Brief review.
    Agents and actions. Supplements, 1992, Volume: 37

    Topics: Animals; Arteriosclerosis; Humans; Platelet Activating Factor

1992
Modification of the eicosanoid system and cell signalling by precursor fatty acids.
    Advances in prostaglandin, thromboxane, and leukotriene research, 1991, Volume: 21A

    Topics: Animals; Arteriosclerosis; Calcium; Cell Division; Dietary Fats; Diglycerides; Eicosanoids; Fatty Acids, Essential; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Free Radicals; Humans; Inflammation; Interleukin-1; Membrane Lipids; Models, Biological; Nitric Oxide; Oxygen; Platelet Activating Factor; Signal Transduction; Tumor Necrosis Factor-alpha

1991
Platelet-activating factor--a powerful lipid autacoid possibly involved in microangiopathy.
    Acta haematologica, 1986, Volume: 75, Issue:3

    Topics: Animals; Arachidonic Acid; Arachidonic Acids; Arteriosclerosis; Blood Platelets; Calmodulin; Capillary Permeability; Chemical Phenomena; Chemistry; Cyclic AMP; Diabetic Angiopathies; Endothelium; Humans; Microcirculation; Neutrophils; Platelet Activating Factor; Steroids; Thrombosis

1986
An overview of antiplatelet and antithrombotic drugs.
    Haemostasis, 1985, Volume: 15, Issue:2

    Topics: Adenosine Diphosphate; Arachidonic Acids; Arteriosclerosis; Blood Platelets; Blood Vessels; Endothelium; Epoprostenol; Erythrocyte Aggregation; Fibrinolytic Agents; Hemostasis; Humans; Phospholipases A; Phospholipids; Platelet Activating Factor; Platelet Adhesiveness; Platelet Aggregation; Prostaglandin Antagonists; Prostaglandins; Receptors, Prostaglandin; Receptors, Thromboxane; Thrombin; Thromboembolism; Thromboxane-A Synthase; Type C Phospholipases

1985

Other Studies

31 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Arteriosclerosis

ArticleYear
Structure elucidation of phenolic compounds from red/white wine with antiatherogenic properties.
    Biochimica et biophysica acta, 2003, Jun-10, Volume: 1632, Issue:1-3

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Antioxidants; Arteriosclerosis; Blood Platelets; Humans; Lipoproteins, LDL; Oxidation-Reduction; Phenols; Phospholipases A; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rabbits; Thrombin; Wine

2003
Intra-plaque production of platelet-activating factor correlates with neoangiogenesis in human carotid atherosclerotic lesions.
    International journal of molecular medicine, 2003, Volume: 12, Issue:3

    Topics: Adult; Aged; Arteriosclerosis; Carotid Artery Diseases; Female; Humans; Macrophages; Male; Middle Aged; Neovascularization, Pathologic; Platelet Activating Factor; Tumor Necrosis Factor-alpha

2003
Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques.
    Proceedings of the National Academy of Sciences of the United States of America, 2004, Aug-10, Volume: 101, Issue:32

    Topics: Animals; Aorta, Thoracic; Apolipoproteins E; Arteriosclerosis; Cell Movement; Disease Progression; Endothelium, Vascular; Female; Kinetics; Lipids; Lysophospholipids; Male; Mice; Mice, Knockout; Monocytes; Platelet Activating Factor; Transplantation, Homologous

2004
Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization.
    Immunity, 2004, Volume: 21, Issue:4

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Apolipoproteins E; Arteriosclerosis; Cell Movement; Cholesterol, HDL; Dendritic Cells; Female; Humans; Hyperlipidemias; Immunohistochemistry; Lipoproteins, LDL; Lymph Nodes; Male; Mice; Mice, Transgenic; Organ Culture Techniques; Platelet Activating Factor; Receptors, LDL; Reverse Transcriptase Polymerase Chain Reaction; Skin

2004
Platelet activating factor induces cytoskeletal reorganization through Rho family pathway in THP-1 macrophages.
    FEBS letters, 2005, Jul-18, Volume: 579, Issue:18

    Topics: Adenoviridae; Arteriosclerosis; beta-Galactosidase; cdc42 GTP-Binding Protein; Cell Line, Tumor; Cytoskeleton; Gene Transfer Techniques; Guanine Nucleotide Dissociation Inhibitors; Guanosine Triphosphate; Humans; Immunoblotting; Inflammation; Macrophages; Platelet Activating Factor; Pseudopodia; rac1 GTP-Binding Protein; rho GTP-Binding Proteins; rho-Specific Guanine Nucleotide Dissociation Inhibitors; rhoA GTP-Binding Protein; Time Factors; Up-Regulation

2005
Effect of platelet-activating factor (PAF) receptor blockers on smooth muscle cell replication in vitro and allograft arteriosclerosis in vivo.
    Transplant international : official journal of the European Society for Organ Transplantation, 1993, Volume: 6, Issue:5

    Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Autoradiography; Azepines; Cell Division; Cells, Cultured; DNA; Dose-Response Relationship, Drug; Fibroblasts; Male; Muscle, Smooth, Vascular; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Inbred WF; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Transplantation, Homologous; Triazoles

1993
Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta.
    Circulation research, 1993, Volume: 72, Issue:1

    Topics: Animals; Aorta; Arteriosclerosis; Endothelium, Vascular; Lipoproteins, LDL; Lysophosphatidylcholines; Lysophospholipase; Male; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Rabbits; Sphingosine; Vasodilation

1993
Phagocytic activation induces formation of platelet-activating factor in human monocyte-derived macrophages and in macrophage-derived foam cells. Relevance to the inflammatory reaction in atherogenesis.
    European journal of biochemistry, 1996, Feb-15, Volume: 236, Issue:1

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetyltransferases; Arteriosclerosis; Cells, Cultured; Foam Cells; Humans; Inflammation; Lipase; Macrophage Activation; Macrophages; Monocytes; Opsonin Proteins; Phagocytosis; Phospholipases A; Platelet Activating Factor; Zymosan

1996
Lack of protection against oxidative modification of LDL by avian HDL.
    Biochemical and biophysical research communications, 1998, Jun-18, Volume: 247, Issue:2

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Arteriosclerosis; Aryldialkylphosphatase; Birds; Cattle; Chickens; Cricetinae; Esterases; Guinea Pigs; Humans; In Vitro Techniques; Lipid Peroxidation; Lipoproteins, HDL; Lipoproteins, LDL; Male; Mice; Mice, Knockout; Models, Biological; Oxidation-Reduction; Phospholipases A; Platelet Activating Factor; Rabbits; Rats; Turkeys

1998
HDL composition and HDL antioxidant capacity in patients on regular haemodialysis.
    Atherosclerosis, 1999, Volume: 143, Issue:1

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Antioxidants; Arteriosclerosis; Aryldialkylphosphatase; beta Carotene; Carotenoids; Cholesterol; Cholesterol Esters; Cholesterol, HDL; Cholesterol, LDL; Esterases; Fatty Acids; Female; Humans; Kidney Failure, Chronic; Lipid Peroxidation; Lycopene; Male; Middle Aged; Oxidation-Reduction; Phospholipases A; Phospholipids; Platelet Activating Factor; Renal Dialysis; Risk Factors; Vitamin E

1999
Ischemia-reperfusion induced microvascular responses in LDL-receptor -/- mice.
    The American journal of physiology, 1999, Volume: 276, Issue:5

    Topics: Animals; Antibodies, Monoclonal; Arteriosclerosis; Cell Adhesion; Hypercholesterolemia; Intercellular Adhesion Molecule-1; Leukocytes; Leukotrienes; Male; Mice; Mice, Knockout; Microcirculation; Myocardial Ischemia; Myocardial Reperfusion Injury; Platelet Activating Factor; Receptors, LDL; Serum Albumin

1999
Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease.
    Atherosclerosis, 1999, Volume: 145, Issue:1

    Topics: Acute-Phase Proteins; Aged; Aged, 80 and over; Arteriosclerosis; CD11 Antigens; Cytokines; Exercise Test; Female; Humans; Inflammation; Inflammation Mediators; Interleukin-1; Interleukin-6; Leukocyte Count; Leukocyte Elastase; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Activating Factor; Receptors, Cytokine; Superoxides; Tumor Necrosis Factor-alpha

1999
Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis : in vitro and In vivo inhibition by WEB 2086.
    Circulation research, 1999, Aug-20, Volume: 85, Issue:4

    Topics: Animals; Arteriosclerosis; Azepines; Cell Adhesion; Cells, Cultured; Endothelium, Vascular; Humans; Lipid Peroxidation; Mice; Monocytes; Phospholipid Ethers; Phospholipids; Platelet Activating Factor; Platelet Aggregation Inhibitors; Triazoles

1999
Antibodies to platelet-activating factor are associated with borderline hypertension, early atherosclerosis and the metabolic syndrome.
    Journal of internal medicine, 1999, Volume: 246, Issue:4

    Topics: Adult; Antibodies; Antibody Specificity; Arteriosclerosis; Blood Pressure; Endothelin-1; Humans; Hypertension; Immunoglobulin G; Insulin-Like Growth Factor Binding Protein 1; Lipoproteins; Male; Middle Aged; Platelet Activating Factor

1999
Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population.
    Atherosclerosis, 2000, Volume: 150, Issue:1

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Aged; Aged, 80 and over; Aging; Arteriosclerosis; Female; Genotype; Humans; Japan; Male; Middle Aged; Mutation, Missense; Phospholipases A; Platelet Activating Factor; Polymerase Chain Reaction; Risk Factors

2000
Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease.
    Atherosclerosis, 2000, Volume: 150, Issue:2

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Aged; Antibodies, Monoclonal; Arteriosclerosis; Biomarkers; Coronary Angiography; Enzyme-Linked Immunosorbent Assay; Humans; Lipids; Male; Middle Aged; Phospholipases A; Platelet Activating Factor; Platelet Activation; Prognosis; Risk Factors

2000
Plasma platelet-activating factor acetylhydrolase deficiency is associated with atherosclerotic occlusive disease in japan.
    Journal of vascular surgery, 2000, Volume: 32, Issue:2

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Aged; Arteriosclerosis; Female; Genotype; Humans; Japan; Male; Mutation; Phospholipases A; Platelet Activating Factor

2000
Oxidized low density lipoproteins downregulate LPS-induced platelet-activating factor receptor expression in human monocyte-derived macrophages: implications for LPS-induced nuclear factor-kappaB binding activity.
    European journal of biochemistry, 2001, Volume: 268, Issue:16

    Topics: Arteriosclerosis; DNA; Down-Regulation; Humans; Lipopolysaccharides; Lipoproteins, LDL; Lysophosphatidylcholines; Macrophages; Monocytes; NF-kappa B; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled

2001
Biologically active lipids with antiatherogenic properties from white wine and must.
    Journal of agricultural and food chemistry, 2002, Apr-24, Volume: 50, Issue:9

    Topics: Acetylation; Animals; Arteriosclerosis; Blood Platelets; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Lipids; Mass Spectrometry; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rabbits; Thrombin; Wine

2002
Atherosclerosis, cell motility, calcium, and calcium-channel blockers.
    Journal of cardiovascular pharmacology, 1992, Volume: 19 Suppl 2

    Topics: Arteriosclerosis; Calcium; Calcium Channel Blockers; Cell Movement; Humans; Lipoproteins, LDL; Platelet Activating Factor; Platelet-Derived Growth Factor

1992
Activation of leukocytes with complement C5a is associated with prostanoid-dependent constriction of large arteries in atherosclerotic monkeys in vivo.
    Atherosclerosis, 1992, Volume: 95, Issue:2-3

    Topics: Animals; Arteries; Arteriosclerosis; Azepines; Bridged Bicyclo Compounds, Heterocyclic; Complement C5a; Fatty Acids, Unsaturated; Hemodynamics; Hydrazines; Leukocytes; Lipids; Macaca fascicularis; Male; Platelet Activating Factor; Prostaglandins; Thromboxane A2; Triazoles; Vasoconstriction

1992
Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokers.
    Heart and vessels, 1990, Volume: 5, Issue:2

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Aged; Aged, 80 and over; Arteriosclerosis; Humans; Lipoproteins; Male; Middle Aged; Phospholipases; Phospholipases A; Platelet Activating Factor; Platelet Aggregation; Smoking

1990
Vascular responses to leukocyte products in atherosclerotic primates.
    Circulation research, 1989, Volume: 65, Issue:4

    Topics: Animals; Arteries; Arteriosclerosis; Dinoprostone; Epoprostenol; Hemodynamics; Leukocyte Count; Leukocytes; Lipids; Macaca fascicularis; Male; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; SRS-A; Vasoconstrictor Agents

1989
Platelet-activating factor in organ transplant rejection.
    Advances in prostaglandin, thromboxane, and leukotriene research, 1989, Volume: 19

    Topics: Animals; Aorta; Arteriosclerosis; Diterpenes; Ginkgolides; Graft Rejection; Lactones; Lymphocytes; Macrophages; Male; Plant Extracts; Platelet Activating Factor; Platelet Aggregation; Rabbits

1989
Protective effect of BN 52021, a specific antagonist of platelet-activating factor (PAF-acether) against diet-induced cholesteryl ester deposition in rabbit aorta.
    Atherosclerosis, 1989, Volume: 78, Issue:2-3

    Topics: Animals; Aorta; Arteriosclerosis; Cholesterol; Cholesterol Esters; Diet, Atherogenic; Diterpenes; Ginkgolides; Lactones; Platelet Activating Factor; Platelet Aggregation; Rabbits; Sterol Esterase; Sterol O-Acyltransferase

1989
Whole blood aggregation and plasma lyso-PAF related to smoking and atherosclerosis.
    Clinical and experimental pharmacology & physiology, 1989, Volume: 16, Issue:7

    Topics: Adenosine Diphosphate; Adult; Aged; Arteriosclerosis; Cell Aggregation; Collagen; Humans; Male; Middle Aged; Platelet Activating Factor; Smoking; Thromboxane B2; Vascular Diseases

1989
Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors.
    Circulation, 1985, Volume: 72, Issue:2

    Topics: 6-Ketoprostaglandin F1 alpha; Adrenergic alpha-Antagonists; Animals; Arteriosclerosis; Coronary Circulation; Coronary Disease; Dogs; Hemodynamics; Imidazoles; Male; Platelet Activating Factor; Platelet Aggregation; Serotonin Antagonists; Thromboxane B2

1985
The degradation of platelet-activating factor in serum and its discriminative value in atherosclerotic patients.
    Thrombosis research, 1988, Dec-15, Volume: 52, Issue:6

    Topics: Apolipoproteins; Arteriosclerosis; Biomarkers; Humans; Lipids; Male; Myocardial Infarction; Platelet Activating Factor; Platelet Function Tests; Predictive Value of Tests

1988
Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis.
    Proceedings of the National Academy of Sciences of the United States of America, 1988, Volume: 85, Issue:8

    Topics: Animals; Arteriosclerosis; Chemotaxis, Leukocyte; Foam Cells; Humans; In Vitro Techniques; Lysophosphatidylcholines; Macrophages; Monocytes; Oxidation-Reduction; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Rabbits; Structure-Activity Relationship

1988
[Endothelial injury as an initiating factor: vascular endothelial cell injury and biosynthesis of PAF].
    Nihon rinsho. Japanese journal of clinical medicine, 1988, Volume: 46, Issue:3

    Topics: Arachidonic Acids; Arteriosclerosis; Endothelium, Vascular; Humans; Platelet Activating Factor; Platelet Adhesiveness

1988
Plasma from atherosclerotic patients exerts an increased degradation of platelet-activating factor.
    Thrombosis research, 1987, Aug-01, Volume: 47, Issue:3

    Topics: Aged; Apolipoproteins; Arteriosclerosis; Cholesterol; Humans; Lipoproteins; Male; Middle Aged; Plasma; Platelet Activating Factor

1987